Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients

ANGPTL3 is independently and strongly associated with DR progression in all stages. Blockade of ANGPTL3 signal in retina might postpone the onset and development of DR in T2DM patients.